Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Colitis, Ulcerative"" wg kryterium: Temat


Tytuł :
Antioxidant and anti-inflammatory effects of hesperidin methyl chalcone in experimental ulcerative colitis.
Autorzy :
Guazelli CFS; Laboratório de Dor, Inflamação, Neuropatia e Câncer, Departamento de Ciências Patológicas, Universidade Estadual de Londrina, Londrina, PR, Brazil.
Fattori V; Laboratório de Dor, Inflamação, Neuropatia e Câncer, Departamento de Ciências Patológicas, Universidade Estadual de Londrina, Londrina, PR, Brazil.
Ferraz CR; Laboratório de Dor, Inflamação, Neuropatia e Câncer, Departamento de Ciências Patológicas, Universidade Estadual de Londrina, Londrina, PR, Brazil; Laboratório de Antioxidantes e Inflamação, Departamento de Ciências Farmacêuticas, Universidade Estadual de Londrina Londrina, Londrina, PR, Brazil.
Borghi SM; Laboratório de Dor, Inflamação, Neuropatia e Câncer, Departamento de Ciências Patológicas, Universidade Estadual de Londrina, Londrina, PR, Brazil; Center for Research in Health Sciences, University of Northern Paraná, Londrina, PR, Brazil.
Casagrande R; Laboratório de Antioxidantes e Inflamação, Departamento de Ciências Farmacêuticas, Universidade Estadual de Londrina Londrina, Londrina, PR, Brazil; Departamento de Ciências Farmacêuticas, Universidade Estadual de Londrina, Londrina, PR, Brazil.
Baracat MM; Departamento de Ciências Farmacêuticas, Universidade Estadual de Londrina, Londrina, PR, Brazil.
Verri WA Jr; Laboratório de Dor, Inflamação, Neuropatia e Câncer, Departamento de Ciências Patológicas, Universidade Estadual de Londrina, Londrina, PR, Brazil. Electronic address: .
Pokaż więcej
Źródło :
Chemico-biological interactions [Chem Biol Interact] 2021 Jan 05; Vol. 333, pp. 109315. Date of Electronic Publication: 2020 Nov 07.
Typ publikacji :
Journal Article
MeSH Terms :
Anti-Inflammatory Agents/*pharmacology
Antioxidants/*pharmacology
Chalcones/*pharmacology
Colitis, Ulcerative/*drug therapy
Hesperidin/*analogs & derivatives
Animals ; Anti-Inflammatory Agents/therapeutic use ; Antioxidants/therapeutic use ; Chalcones/therapeutic use ; Colitis, Ulcerative/complications ; Colitis, Ulcerative/immunology ; Colitis, Ulcerative/metabolism ; Colon/drug effects ; Colon/pathology ; Cytokines/biosynthesis ; Disease Models, Animal ; Edema/complications ; Hesperidin/pharmacology ; Hesperidin/therapeutic use ; Male ; Mice ; NF-kappa B/metabolism ; Neutrophil Infiltration/drug effects ; Oxidative Stress/drug effects
Czasopismo naukowe
Tytuł :
Feiyangchangweiyan capsule protects against ulcerative colitis in mice by modulating the OSM/OSMR pathway and improving gut microbiota.
Autorzy :
Li Y; Northwest University, Faculty of Life Science & Medicine, Key Laboratory Resource Biology & Biotechnology in Western China, Ministry of Education, Xi'an 710069, Shaanxi, China.
Chen F; Department of Emergency Surgery, Wuhan No.1 Hospital, No.215 Zhongshan Road, Wuhan 430022, China.
Xie Y; Northwest University, Faculty of Life Science & Medicine, Key Laboratory Resource Biology & Biotechnology in Western China, Ministry of Education, Xi'an 710069, Shaanxi, China.
Yang Q; Department of Chinese Materia Medica and Natural Medicines, Air Force Medical University, Changle West Road No.169, Xi'an 710032 Shaanxi, P.R. China.
Luo H; Northwest University, Faculty of Life Science & Medicine, Key Laboratory Resource Biology & Biotechnology in Western China, Ministry of Education, Xi'an 710069, Shaanxi, China.
Jia P; Northwest University, Faculty of Life Science & Medicine, Key Laboratory Resource Biology & Biotechnology in Western China, Ministry of Education, Xi'an 710069, Shaanxi, China.
Shi Z; Shaanxi Junbisha Pharmaceutical Limited Company, Xianyang 712015, Shaanxi, China.
Wang S; Northwest University, Faculty of Life Science & Medicine, Key Laboratory Resource Biology & Biotechnology in Western China, Ministry of Education, Xi'an 710069, Shaanxi, China; Department of Chinese Materia Medica and Natural Medicines, Air Force Medical University, Changle West Road No.169, Xi'an 710032 Shaanxi, P.R. China. Electronic address: .
Zheng X; Northwest University, Faculty of Life Science & Medicine, Key Laboratory Resource Biology & Biotechnology in Western China, Ministry of Education, Xi'an 710069, Shaanxi, China. Electronic address: .
Pokaż więcej
Źródło :
Phytomedicine : international journal of phytotherapy and phytopharmacology [Phytomedicine] 2021 Jan; Vol. 80, pp. 153372. Date of Electronic Publication: 2020 Oct 17.
Typ publikacji :
Journal Article
MeSH Terms :
Colitis, Ulcerative/*drug therapy
Drugs, Chinese Herbal/*pharmacology
Gastrointestinal Microbiome/*drug effects
Oncostatin M/*metabolism
Oncostatin M Receptor beta Subunit/*metabolism
Animals ; Anti-Inflammatory Agents, Non-Steroidal/pharmacology ; Capsules ; Chemokines/blood ; Colitis, Ulcerative/chemically induced ; Colitis, Ulcerative/microbiology ; Colon/drug effects ; Colon/metabolism ; Colon/pathology ; Colon/ultrastructure ; Cytokines/blood ; Dextran Sulfate/toxicity ; Disease Models, Animal ; Gastrointestinal Microbiome/genetics ; Male ; Mice, Inbred C57BL ; Oncostatin M/genetics ; Oncostatin M Receptor beta Subunit/genetics ; Protective Agents/pharmacology
Czasopismo naukowe
Tytuł :
Changes in serum inflammatory cytokine levels and intestinal flora in a self-healing dextran sodium sulfate-induced ulcerative colitis murine model.
Autorzy :
Jialing L; Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Yangyang G; Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Jing Z; Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Xiaoyi T; Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Ping W; Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Liwei S; Chengdu University of Traditional Chinese Medicine, Chengdu, China. Electronic address: .
Simin C; Chengdu University of Traditional Chinese Medicine, Chengdu, China. Electronic address: .
Pokaż więcej
Źródło :
Life sciences [Life Sci] 2020 Dec 15; Vol. 263, pp. 118587. Date of Electronic Publication: 2020 Oct 13.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Gastrointestinal Microbiome*
Colitis, Ulcerative/*physiopathology
Cytokines/*blood
Inflammation/*physiopathology
Animals ; Colitis, Ulcerative/immunology ; Colitis, Ulcerative/microbiology ; Dextran Sulfate ; Disease Models, Animal ; Inflammation/immunology ; Inflammation/microbiology ; Male ; Mice ; Time Factors
Czasopismo naukowe
Tytuł :
Prevalence of IBS-type symptoms in IBD.
Autorzy :
Strid H; Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, 40530 Gothenburg, Sweden. Electronic address: .
Pokaż więcej
Źródło :
The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2020 Dec; Vol. 5 (12), pp. 1029-1031. Date of Electronic Publication: 2020 Oct 02.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Colitis, Ulcerative*/diagnosis
Colitis, Ulcerative*/epidemiology
Inflammatory Bowel Diseases*/diagnosis
Inflammatory Bowel Diseases*/epidemiology
Irritable Bowel Syndrome*/diagnosis
Irritable Bowel Syndrome*/epidemiology
Humans ; Prevalence
Czasopismo naukowe
Tytuł :
Periplaneta americana extract promotes intestinal mucosa repair of ulcerative colitis in rat.
Autorzy :
Xue NN; Master, Yunnan Provincial, Key Laboratory of Entomological Biopharmaceutical R&D, Dali University, Yunnan, China. Acquisition of data, manuscript preparation.
He M; PhD, National-Local Joint Engineering Research Center of Entomoceutics, Dali University, Yunnan, China. Critical revision, final approval.
Li Y; Master, Yunnan Provincial, Key Laboratory of Entomological Biopharmaceutical R&D, Dali University, Yunnan, China. Acquisition of data, manuscript preparation.
Wu JZ; Master, Yunnan Provincial, Key Laboratory of Entomological Biopharmaceutical R&D, Dali University, Yunnan, China. Acquisition of data, manuscript preparation.
Du WW; Master, The People's Hospital of Linqing, Shandong Province, China. Acquisition, analysis and interpretation of data.
Wu XM; PhD, Yunnan Provincial, Key Laboratory of Entomological Biopharmaceutical R&D, Dali University, Yunnan, China. Conception and design of the study, manuscript writing, final approval.
Yang ZZ; PhD, Yunnan Provincial, Key Laboratory of Entomological Biopharmaceutical R&D, Dali University, Yunnan, China. Conception and design of the study, manuscript writing, final approval.
Zhang CG; PhD, Yunnan Provincial, Key Laboratory of Entomological Biopharmaceutical R&D, Dali University, Yunnan, China. Conception and design of the study, manuscript writing, final approval.
Li QY; PhD, The First People's Hospital of Yunnan Province, Kunming, Yunnan Province, China. Histopathological examinations, critical revision, final approval.
Xiao H; PhD, National-Local Joint Engineering Research Center of Entomoceutics, Dali University, Yunnan, China. Critical revision, final approval.
Pokaż więcej
Źródło :
Acta cirurgica brasileira [Acta Cir Bras] 2020 Nov 23; Vol. 35 (10), pp. e202001002. Date of Electronic Publication: 2020 Nov 23 (Print Publication: 2020).
Typ publikacji :
Journal Article
MeSH Terms :
Colitis, Ulcerative*/chemically induced
Colitis, Ulcerative*/drug therapy
Periplaneta*
Animals ; Colon ; Female ; Intestinal Mucosa ; Male ; Plant Extracts/pharmacology ; Plant Extracts/therapeutic use ; Rats ; Rats, Sprague-Dawley
Czasopismo naukowe
Tytuł :
[Mechanism and experimental verification of Sijunzi Decoction in treatment of ulcerative colitis based on network pharmacology].
Autorzy :
Meng-Long Z; Graduate School of Guangxi University of Traditional Chinese Medicine Nanning 530001, China.
Xiao-Yan H; the First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine Nanning 530023, China.
Ya-Lu C; the First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine Nanning 530023, China.
Xin N; Graduate School of Guangxi University of Traditional Chinese Medicine Nanning 530001, China.
Qing-Ting R; Graduate School of Guangxi University of Traditional Chinese Medicine Nanning 530001, China.
Zhen-Yi L; Graduate School of Guangxi University of Traditional Chinese Medicine Nanning 530001, China.
Li-Qun LI; the First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine Nanning 530023, China.
Pokaż więcej
Źródło :
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica [Zhongguo Zhong Yao Za Zhi] 2020 Nov; Vol. 45 (22), pp. 5362-5372.
Typ publikacji :
Journal Article
MeSH Terms :
Colitis, Ulcerative*/drug therapy
Colitis, Ulcerative*/genetics
Drugs, Chinese Herbal*/pharmacology
Animals ; Medicine, Chinese Traditional ; Mice ; Vascular Endothelial Growth Factor A
Czasopismo naukowe
Tytuł :
Onset of ulcerative colitis during SARS-CoV-2 infection.
Autorzy :
Calabrese E; Gastroenterology Unit, Department of Systems Medicine, University of Rome Tor Vergata, Italy. Electronic address: .
Zorzi F; Gastroenterology Unit, Department of Systems Medicine, University of Rome Tor Vergata, Italy.
Monteleone G; Gastroenterology Unit, Department of Systems Medicine, University of Rome Tor Vergata, Italy.
Del Vecchio Blanco G; Gastroenterology Unit, Department of Systems Medicine, University of Rome Tor Vergata, Italy.
Pokaż więcej
Źródło :
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2020 Nov; Vol. 52 (11), pp. 1228-1229. Date of Electronic Publication: 2020 Jun 11.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Colitis, Ulcerative/*etiology
Coronavirus Infections/*complications
Pneumonia, Viral/*complications
Betacoronavirus ; COVID-19 ; Colitis, Ulcerative/diagnostic imaging ; Colitis, Ulcerative/pathology ; Colitis, Ulcerative/virology ; Coronavirus Infections/diagnosis ; Female ; Humans ; Pandemics ; Pneumonia, Viral/diagnosis ; SARS-CoV-2 ; Ultrasonography ; Young Adult
Czasopismo naukowe
Tytuł :
Comprehensive analysis of key biomarkers, immune infiltration and potential therapeutic agents for ulcerative colitis.
Autorzy :
Lei Y; Department of Gastroenterology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China.
Chen Y; Department of Gastroenterology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China.
Lin Z; Department of Gastroenterology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China.
Tian D; Department of Gastroenterology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China. Electronic address: .
Han P; Department of Gastroenterology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China. Electronic address: .
Pokaż więcej
Źródło :
Life sciences [Life Sci] 2020 Nov 01; Vol. 260, pp. 118437. Date of Electronic Publication: 2020 Sep 17.
Typ publikacji :
Journal Article
MeSH Terms :
Transcriptome*
Anti-Inflammatory Agents, Non-Steroidal/*pharmacology
Colitis, Ulcerative/*drug therapy
Colitis, Ulcerative/*immunology
Meclofenamic Acid/*pharmacology
Animals ; Case-Control Studies ; Colitis/chemically induced ; Colitis/drug therapy ; Colitis, Ulcerative/genetics ; Dextran Sulfate/toxicity ; Disease Models, Animal ; Drug Evaluation, Preclinical ; Female ; Genetic Markers/genetics ; Humans ; Mice, Inbred C57BL ; Protein Interaction Maps/genetics
Czasopismo naukowe
Tytuł :
Use of Biological Medications Does Not Increase Postoperative Complications Among Patients With Ulcerative Colitis Undergoing Colectomy: A Retrospective Cohort Analysis of Privately Insured Patients.
Autorzy :
Rumer KK; Department of Surgery, Stanford University School of Medicine, Stanford, California.
Dehghan MS
Sceats LA
Trickey AW
Morris AM
Kin C
Pokaż więcej
Źródło :
Diseases of the colon and rectum [Dis Colon Rectum] 2020 Nov; Vol. 63 (11), pp. 1524-1533.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Biological Products*/administration & dosage
Biological Products*/adverse effects
Colitis, Ulcerative*/drug therapy
Colitis, Ulcerative*/surgery
Ileostomy*/adverse effects
Ileostomy*/methods
Postoperative Complications*/etiology
Postoperative Complications*/surgery
Proctocolectomy, Restorative*/adverse effects
Proctocolectomy, Restorative*/methods
Clinical Decision-Making/methods ; Female ; Humans ; Insurance Claim Review ; Male ; Middle Aged ; Operative Time ; Outcome and Process Assessment, Health Care ; Patient Preference/statistics & numerical data ; Patient Readmission/statistics & numerical data ; Retrospective Studies ; United States
Czasopismo naukowe
Tytuł :
Levels of Anti-Citrullinated Protein Antibodies and Rheumatoid Factor, Including IgA Isotypes, and Articular Manifestations in Ulcerative Colitis and Crohn's Disease.
Autorzy :
Janssen KMJ; Department of Oral and Maxillofacial Surgery, University of Groningen and University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands.
Hop H; Department of Internal Medicine, University of Groningen and University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands.
Vissink A; Department of Oral and Maxillofacial Surgery, University of Groningen and University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands.
Dijkstra G; Department of Gastroenterology and Hepatology, University of Groningen and University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands.
de Smit MJ; Department of Oral and Maxillofacial Surgery, University of Groningen and University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands.; Department of Rheumatology and Clinical Immunology, University of Groningen and University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands.
Brouwer E; Department of Rheumatology and Clinical Immunology, University of Groningen and University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands.
Westra J; Department of Rheumatology and Clinical Immunology, University of Groningen and University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands.
Pokaż więcej
Źródło :
International journal of environmental research and public health [Int J Environ Res Public Health] 2020 Nov 01; Vol. 17 (21). Date of Electronic Publication: 2020 Nov 01.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-Citrullinated Protein Antibodies/*metabolism
Arthritis, Rheumatoid/*blood
Autoantibodies/*immunology
Colitis, Ulcerative/*blood
Crohn Disease/*blood
Rheumatoid Factor/*immunology
Adult ; Aged ; Arthritis, Rheumatoid/diagnosis ; Arthritis, Rheumatoid/epidemiology ; Arthritis, Rheumatoid/immunology ; Autoantibodies/blood ; Case-Control Studies ; Colitis, Ulcerative/diagnosis ; Colitis, Ulcerative/epidemiology ; Colitis, Ulcerative/immunology ; Crohn Disease/diagnosis ; Crohn Disease/epidemiology ; Crohn Disease/immunology ; Female ; Humans ; Immunoglobulin A/blood ; Immunoglobulin A/immunology ; Inflammatory Bowel Diseases/blood ; Middle Aged ; Prevalence ; Rheumatoid Factor/blood
Czasopismo naukowe
Tytuł :
Enhanced therapeutic efficacy of a novel colon-specific nanosystem loading emodin on DSS-induced experimental colitis.
Autorzy :
Wang D; Department of Pharmaceutics, School of Pharmacy, Tongji Medical College of Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, PR China.
Sun M; Department of Pharmaceutics, Affiliated Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan 430030, PR China.
Zhang Y; Department of Pharmaceutics, School of Pharmacy, Tongji Medical College of Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, PR China.
Chen Z; Department of Pharmacy, Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, 1227 Jiefang Road, Wuhan 430030, PR China.
Zang S; Department of Pharmaceutics, School of Pharmacy, Tongji Medical College of Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, PR China.
Li G; Department of Pharmaceutics, School of Pharmacy, Tongji Medical College of Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, PR China.
Li G; Department of Pharmaceutics, School of Pharmacy, Tongji Medical College of Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, PR China.
Clark AR; School of Medicine, Indiana University, 975W. Walnut St, IB 008, Indianapolis, IN 46202, USA.
Huang J; Department of Pharmaceutics, School of Pharmacy, Tongji Medical College of Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, PR China. Electronic address: .
Si L; Department of Pharmaceutics, School of Pharmacy, Tongji Medical College of Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, PR China. Electronic address: .
Pokaż więcej
Źródło :
Phytomedicine : international journal of phytotherapy and phytopharmacology [Phytomedicine] 2020 Nov; Vol. 78, pp. 153293. Date of Electronic Publication: 2020 Jul 25.
Typ publikacji :
Journal Article
MeSH Terms :
Colitis, Ulcerative/*drug therapy
Drug Delivery Systems/*methods
Emodin/*pharmacology
Nanostructures/*chemistry
Administration, Oral ; Animals ; Caco-2 Cells ; Colitis, Ulcerative/chemically induced ; Colitis, Ulcerative/pathology ; Cyclooxygenase 2/genetics ; Cyclooxygenase 2/metabolism ; Dextran Sulfate/toxicity ; Disease Models, Animal ; Emodin/administration & dosage ; Emodin/adverse effects ; Emodin/pharmacokinetics ; Glutathione ; Humans ; Hydrogen-Ion Concentration ; Intestinal Mucosa/drug effects ; Male ; Mice, Inbred BALB C ; Mucin-2/genetics ; Nanostructures/administration & dosage ; Nitric Oxide Synthase Type II/genetics ; Nitric Oxide Synthase Type II/metabolism ; Polymethacrylic Acids/chemistry ; Tight Junctions/drug effects ; Tight Junctions/genetics ; Tissue Distribution
Czasopismo naukowe
Tytuł :
[DISABILITY AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASES: A CROSS SECTIONAL STUDY].
Autorzy :
Reches L; Medical Corps, Israeli Defense Forces.
Israeli E; Institute of Gastroenterology and Liver Diseases, E. Wolfson Medical Center, Holon.; Sackler Faculty of Medicine, Tel- Aviv University, Tel Aviv.
Pokaż więcej
Źródło :
Harefuah [Harefuah] 2020 Nov; Vol. 159 (11), pp. 815-819.
Typ publikacji :
Journal Article
MeSH Terms :
Colitis, Ulcerative*/diagnosis
Colitis, Ulcerative*/epidemiology
Inflammatory Bowel Diseases*/diagnosis
Inflammatory Bowel Diseases*/epidemiology
Cross-Sectional Studies ; Humans ; Israel/epidemiology ; Quality of Life ; Severity of Illness Index
Czasopismo naukowe
Tytuł :
Harnessing localised delivery of gut-selective therapy for ulcerative colitis.
Autorzy :
Ma C; Division of Gastroenterology and Hepatology, University of Calgary, Calgary, AB T2N 4Z6, Canada; Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada. Electronic address: .
Panaccione R; Division of Gastroenterology and Hepatology, University of Calgary, Calgary, AB T2N 4Z6, Canada.
Pokaż więcej
Źródło :
The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2020 Dec; Vol. 5 (12), pp. 1031-1032. Date of Electronic Publication: 2020 Oct 05.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Colitis, Ulcerative*/drug therapy
Gastrointestinal Microbiome*
Probiotics*
Double-Blind Method ; Humans
Czasopismo naukowe
Tytuł :
Cobitolimod for moderate-to-severe, left-sided ulcerative colitis (CONDUCT): a phase 2b randomised, double-blind, placebo-controlled, dose-ranging induction trial.
Autorzy :
Atreya R; Medical Clinic 1, Department of Medicine, University Hospital Erlangen, University of Erlangen-Nürnberg, Erlangen, Germany; Deutsches Zentrum Immuntherapie, Erlangen, Germany. Electronic address: .
Peyrin-Biroulet L; Department of Gastroenterology, Nancy University Hospital, Vandoeuvre-lès-Nancy, France; Inserm U1256 NGERE, Lorraine University, Vandoeuvre-lès-Nancy, France.
Klymenko A; Department of Faculty Surgery, Zaporizhzhia Medical University, Zaporizhzhi, Ukraine.
Augustyn M; Centrum Medyczne Plejady, Krakow, Poland.
Bakulin I; Department of Propedeutics of Internal Diseases, Gastroenterology and Dietology, Mechnikov North-Western State Medical University, Saint-Petersburg, Russia.
Slankamenac D; Department of Gastroenterology, General Hospital, Zrenjanin, Serbia.
Miheller P; 1st Department of Surgery, Gastroenterology Unit, Semmelweis University, Budapest, Hungary.
Gasbarrini A; Department of Internal Medicine and Gastroenterology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Hébuterne X; Department of Gastroenterology and Clinical Nutrition, CHU de Nice and University Côte d'Azur, Nice, France.
Arnesson K; InDex Pharmaceuticals, Stockholm, Sweden.
Knittel T; InDex Pharmaceuticals, Stockholm, Sweden.
Kowalski J; JK Biostatistics, Stockholm, Sweden.
Neurath MF; Medical Clinic 1, Department of Medicine, University Hospital Erlangen, University of Erlangen-Nürnberg, Erlangen, Germany; Deutsches Zentrum Immuntherapie, Erlangen, Germany.
Sandborn WJ; Division of Gastroenterology, University of California San Diego, La Jolla, CA, USA.
Reinisch W; Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria.
Pokaż więcej
Corporate Authors :
CONDUCT study group
Źródło :
The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2020 Dec; Vol. 5 (12), pp. 1063-1075. Date of Electronic Publication: 2020 Oct 05.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-Inflammatory Agents, Non-Steroidal/*administration & dosage
Colitis, Ulcerative/*drug therapy
Colitis, Ulcerative/pathology ; Dose-Response Relationship, Drug ; Double-Blind Method ; Europe ; Female ; Humans ; Male ; Middle Aged ; Remission Induction ; Severity of Illness Index ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Direct oral anticoagulants increase the risk of anaemia and hospitalization in IBD patients with active intestinal disease.
Autorzy :
Viola A; Gastroenterology and IBD Unit, Dept of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
Chiappetta MF; Gastroenterology and IBD Unit, Dept of Clinical and Experimental Medicine, University of Messina, Messina, Italy; Section of Gastroenterology and Hepatology, PROMISE, Policlinico Universitario Paolo Giaccone, Palermo, Italy.
Scolaro M; Internal Medicine, Dept. of Clinical and Experimental Medicine, University of Messina, Italy.
Bignoli F; Gastroenterology and IBD Unit, Dept of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
Versace A; Internal Medicine, Dept. of Clinical and Experimental Medicine, University of Messina, Italy.
Fries W; Gastroenterology and IBD Unit, Dept of Clinical and Experimental Medicine, University of Messina, Messina, Italy. Electronic address: .
Pokaż więcej
Źródło :
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2020 Dec; Vol. 52 (12), pp. 1525-1526. Date of Electronic Publication: 2020 Sep 06.
Typ publikacji :
Letter; Comment
MeSH Terms :
Anemia*/chemically induced
Anemia*/epidemiology
Colitis, Ulcerative*
Gastroenterologists*
Anticoagulants/adverse effects ; Hospitalization ; Humans
Opinia redakcyjna
Tytuł :
Will COVID-19 Infection be Less Severe in Ulcerative Colitis Than in Crohn's Patients, Due to a Lower Rate of Smokers?
Autorzy :
Peyrin-Biroulet C; Department of Pneumology, Nancy University Hospital, Vandoeuvre-les-Nancy, France.
D'Amico F; Department of Biomedical Sciences, Humanitas University, Milan, Italy.; Department of Gastroenterology and Inserm NGERE U1256, University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France.
Peyrin-Biroulet L; Department of Gastroenterology and Inserm NGERE U1256, University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France.
Pokaż więcej
Źródło :
Journal of Crohn's & colitis [J Crohns Colitis] 2020 Nov 07; Vol. 14 (11), pp. 1648.
Typ publikacji :
Letter
MeSH Terms :
Betacoronavirus*
Severity of Illness Index*
Colitis, Ulcerative/*complications
Coronavirus Infections/*diagnosis
Crohn Disease/*complications
Pneumonia, Viral/*diagnosis
Smoking/*adverse effects
COVID-19 ; Colitis, Ulcerative/psychology ; Coronavirus Infections/complications ; Crohn Disease/psychology ; Global Health ; Humans ; Pandemics ; Pneumonia, Viral/complications ; Prognosis ; SARS-CoV-2 ; Smoking/epidemiology
Opinia redakcyjna
Tytuł :
Low frequency of COVID-19 in inflammatory bowel diseases.
Autorzy :
Marafini I; Department of Systems Medicine, University of Rome 'TOR VERGATA', Rome, Italy; IBD group of Tor Vergata University Hospital, Rome, Italy.
Salvatori S; Department of Systems Medicine, University of Rome 'TOR VERGATA', Rome, Italy; IBD group of Tor Vergata University Hospital, Rome, Italy.
Sena G; Department of Systems Medicine, University of Rome 'TOR VERGATA', Rome, Italy; IBD group of Tor Vergata University Hospital, Rome, Italy.
Calabrese E; Department of Systems Medicine, University of Rome 'TOR VERGATA', Rome, Italy; IBD group of Tor Vergata University Hospital, Rome, Italy.
Biancone L; Department of Systems Medicine, University of Rome 'TOR VERGATA', Rome, Italy; IBD group of Tor Vergata University Hospital, Rome, Italy.
Monteleone G; Department of Systems Medicine, University of Rome 'TOR VERGATA', Rome, Italy; IBD group of Tor Vergata University Hospital, Rome, Italy. Electronic address: .
Pokaż więcej
Źródło :
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2020 Nov; Vol. 52 (11), pp. 1234-1235. Date of Electronic Publication: 2020 Jun 13.
Typ publikacji :
Letter; Comment
MeSH Terms :
Colitis, Ulcerative*/epidemiology
Coronavirus Infections*
Inflammatory Bowel Diseases*/epidemiology
Pandemics*
Pneumonia, Viral*
Severe Acute Respiratory Syndrome*
Betacoronavirus ; COVID-19 ; Humans ; Italy ; SARS-CoV-2
Opinia redakcyjna
Tytuł :
Effectiveness of Dose De-escalation of Biologic Therapy in Inflammatory Bowel Disease: A Systematic Review.
Autorzy :
Little DHW; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Tabatabavakili S; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Shaffer SR; Inflammatory Bowel Disease Center, University of Chicago Medicine, Chicago, Illinois, USA.
Nguyen GC; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; Mount Sinai Hospital Inflammatory Bowel Disease Centre, University of Toronto, Toronto, Ontario, Canada.
Weizman AV; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; Mount Sinai Hospital Inflammatory Bowel Disease Centre, University of Toronto, Toronto, Ontario, Canada.
Targownik LE; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; Mount Sinai Hospital Inflammatory Bowel Disease Centre, University of Toronto, Toronto, Ontario, Canada.
Pokaż więcej
Źródło :
The American journal of gastroenterology [Am J Gastroenterol] 2020 Nov; Vol. 115 (11), pp. 1768-1774.
Typ publikacji :
Journal Article; Systematic Review
MeSH Terms :
Drug Tapering*
Biological Products/*administration & dosage
Colitis, Ulcerative/*drug therapy
Crohn Disease/*drug therapy
Gastrointestinal Agents/*administration & dosage
Inflammatory Bowel Diseases/*drug therapy
Tumor Necrosis Factor Inhibitors/*administration & dosage
Adalimumab/administration & dosage ; Antibodies, Monoclonal, Humanized/administration & dosage ; Colitis, Ulcerative/physiopathology ; Crohn Disease/physiopathology ; Humans ; Inflammatory Bowel Diseases/physiopathology ; Infliximab/administration & dosage ; Recurrence
Czasopismo naukowe
Tytuł :
Antibiotics: a trigger for inflammatory bowel disease?
Autorzy :
Sokol H; Sorbonne Université, Institut national de la santé et de la recherche médical, Centre de Recherche Saint-Antoine, Assistance publique - Hôpitaux de Paris, Saint Antoine Hospital, Gastroenterology department, F-75012 Paris, France; Institut national de la recherche agronomique, UMR1319 Micalis and AgroParisTech, Jouy en Josas, France; Paris Centre for Microbiome Medicine, Fédération hospitalo-universitaires, Paris, France. Electronic address: .
Pokaż więcej
Źródło :
The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2020 Nov; Vol. 5 (11), pp. 956-957. Date of Electronic Publication: 2020 Aug 17.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Colitis, Ulcerative*/drug therapy
Inflammatory Bowel Diseases*/drug therapy
Anti-Bacterial Agents/adverse effects ; Case-Control Studies ; Humans ; Sweden
Czasopismo naukowe
Tytuł :
[Increased neoplastic risks in ulcerative colitis associated with primary sclerosing cholangitis].
Autorzy :
Kouam C; Service d'Hépato-Gastroentérologie et d'Oncologie digestive, CHU Liège, Belgique.
Warling O; Service d'Hépato-Gastroentérologie et d'Oncologie digestive, CHU Liège, Belgique.
Van Kemseke C; Service d'Hépato-Gastroentérologie et d'Oncologie digestive, CHU Liège, Belgique.
Loly JP; Service d'Hépato-Gastroentérologie et d'Oncologie digestive, CHU Liège, Belgique.
Louis E; Service d'Hépato-Gastroentérologie et d'Oncologie digestive, CHU Liège, Belgique.
Delwaide J; Service d'Hépato-Gastroentérologie et d'Oncologie digestive, CHU Liège, Belgique.
Pokaż więcej
Transliterated Title :
Risques néoplasiques majorés dans la rectocolite ulcéro-hémorragique associée à la cholangite sclérosante primitive.
Źródło :
Revue medicale de Liege [Rev Med Liege] 2020 Nov; Vol. 75 (11), pp. 724-730.
Typ publikacji :
Case Reports; Journal Article; Review
MeSH Terms :
Bile Duct Neoplasms*
Cholangiocarcinoma*
Cholangitis, Sclerosing*/complications
Colitis, Ulcerative*/complications
Bile Ducts, Intrahepatic ; Humans
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies